The STAMBP Gene Microcephaly-Capillary Malformation Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the STAMBP gene, which are associated with Microcephaly-Capillary Malformation Syndrome (MIC-CAP). This rare genetic disorder is characterized by microcephaly, where an infant's head is significantly smaller than expected, and capillary malformations, which are distinctive, small, red to purple spots on the skin. The condition may also involve a range of other physical and developmental challenges.
DNA Labs UAE provides this crucial genetic testing service for a fee of 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in their state-of-the-art laboratory. The aim is to detect any abnormalities in the STAMBP gene that could indicate the presence of MIC-CAP syndrome. This information is vital for early diagnosis, which can significantly impact the management and treatment of the condition, allowing healthcare providers to offer targeted support and interventions to improve the quality of life for affected individuals and their families.
The "RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at identifying mutations in the RYR1 gene, which are known to cause Minicore Myopathy with External Ophthalmoplegia. This condition is a rare genetic disorder characterized by muscle weakness, respiratory issues, and external ophthalmoplegia, which is a condition affecting eye movement. The RYR1 gene plays a crucial role in muscle contraction, and mutations in this gene can lead to the aforementioned symptoms.
The genetic test involves analyzing the patient's DNA to detect abnormalities in the RYR1 gene, providing valuable information for diagnosis, treatment planning, and genetic counseling. It is particularly useful for families with a history of the disorder, offering insights into the risk of passing the condition to offspring.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the testing and the comprehensive analysis required to accurately identify mutations in the RYR1 gene. Conducted at DNA Labs UAE, the test represents an important resource for individuals and families affected by Minicore Myopathy with External Ophthalmoplegia, facilitating early diagnosis and intervention for this rare condition.
The "DCC Gene Mirror Movements Type 1 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the DCC gene, which are linked to Mirror Movements Type 1 disorder. This condition is characterized by involuntary movements on one side of the body that mirror intentional movements on the opposite side, often affecting the hands and limbs. Such mutations can lead to disruptions in the normal development of nerve fibers, affecting coordination and movement.
Priced at 4400 AED, the test involves analyzing the patient's DNA to detect any genetic anomalies in the DCC gene, providing crucial information for the diagnosis, management, and understanding of the disorder. Conducted in the advanced facilities of DNA Labs UAE, the test is a vital tool for individuals experiencing symptoms of mirror movements, offering them a clear genetic insight into their condition and guiding their treatment options.
The "RAD51 Gene Mirror Movements Type 2 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the RAD51 gene, which are linked to the development of Mirror Movements Type 2. This condition is characterized by involuntary symmetrical movements of one side of the body mirroring intentional movements on the opposite side. The test is crucial for individuals exhibiting symptoms of this disorder or those with a family history, as it aids in confirming the diagnosis and facilitating appropriate management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific genetic alterations in the RAD51 gene that are associated with the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify these mutations.
Early detection through the RAD51 Gene Mirror Movements Type 2 Genetic Test can significantly benefit affected individuals by enabling timely intervention and support, thereby improving quality of life and reducing the risk of complications associated with uncoordinated movements.
The "DNAL4 Gene Mirror Movements Type 3 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the DNAL4 gene associated with Mirror Movements Type 3. This condition is characterized by involuntary mirroring of movements in symmetrical limbs, often noticeable when an individual attempts to perform unilateral tasks. The test plays a crucial role in the accurate diagnosis and understanding of the genetic basis of this rare disorder, facilitating tailored management and therapy options for affected individuals.
Administered with precision and care at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. Advanced genetic sequencing techniques are then employed to scrutinize the DNAL4 gene for specific mutations that contribute to the development of Mirror Movements Type 3.
Priced at 4400 AED, the test represents a significant step towards personalized medicine, offering insights that can guide healthcare professionals in crafting bespoke treatment plans. It also provides valuable information for affected families regarding the inheritance patterns and potential implications for future generations.
The FOXRED1 Gene Mitochondrial Complex I Deficiency Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FOXRED1 gene, which are associated with mitochondrial complex I deficiency. This condition is a rare genetic disorder that affects the mitochondrial respiratory chain, leading to a range of clinical manifestations including muscle weakness, heart disease, and neurological deficits. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic variations in the FOXRED1 gene that might disrupt the normal function of complex I, one of the key enzymes involved in cellular energy production. This precise genetic testing is crucial for confirming a diagnosis, guiding treatment options, and providing information on the risk of passing the condition to future generations. DNA Labs UAE employs advanced genetic testing technologies to ensure accurate and reliable results, supporting patients and their families in managing and understanding their genetic health.
The "MT-ND1 Gene Mitochondrial Complex I Deficiency Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MT-ND1 gene. This gene plays a crucial role in the proper functioning of Complex I, a key enzyme complex in the mitochondrial respiratory chain responsible for energy production in cells. Mutations in the MT-ND1 gene can lead to mitochondrial complex I deficiency, a condition that can cause a wide range of symptoms, including muscle weakness, neurological problems, and organ dysfunction. This genetic test is vital for the early detection and management of the condition, facilitating personalized treatment plans to improve patient outcomes. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the mitochondrial DNA. Conducted at DNA Labs UAE, this test represents a crucial step forward in the diagnosis and management of mitochondrial disorders, offering hope to affected individuals and their families.
The "MT-ND2 Gene Mitochondrial Complex I Deficiency Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the MT-ND2 gene, which is known to be associated with mitochondrial complex I deficiency. This condition is a type of mitochondrial disorder that affects the mitochondrial complex I - the first enzyme complex in the mitochondrial respiratory chain. Mutations in the MT-ND2 gene can lead to a variety of clinical manifestations, including neurodegenerative diseases, muscle weakness, and metabolic syndromes, making early and accurate diagnosis crucial for management and treatment.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the MT-ND2 gene to detect any genetic alterations that may contribute to mitochondrial complex I deficiency. With a cost of 4400 AED, the test is conducted using advanced molecular techniques to ensure high sensitivity and specificity, providing essential information for patients and healthcare providers to make informed decisions regarding the condition's management. The result from this test can also help in understanding the genetic basis of the disorder, guiding treatment options, and offering genetic counseling for affected families.
The MT-ND3 gene mitochondrial complex I deficiency genetic test is a specialized diagnostic procedure aimed at detecting mutations in the MT-ND3 gene, which is crucial for the normal function of mitochondrial complex I. Mitochondrial complex I is a vital component of the mitochondrial respiratory chain, responsible for energy production within cells. Mutations in the MT-ND3 gene can lead to mitochondrial complex I deficiency, a condition that affects various body systems, particularly the nervous system and muscles, leading to a wide range of clinical manifestations from mild to severe.
This genetic test involves analyzing the patient's DNA to identify mutations in the MT-ND3 gene, providing crucial information for the diagnosis, prognosis, and management of the condition. Early detection through this test can enable timely intervention and management strategies to mitigate the symptoms and improve the quality of life for affected individuals.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high-quality testing and reliable results. The cost of the MT-ND3 gene mitochondrial complex I deficiency genetic test is 4400 AED. Patients seeking this test can expect professional service, including pre-test counseling, efficient sample collection, and post-test guidance to understand their results and the implications for their health and potential treatment options.
The MT-ND4 gene plays a crucial role in the mitochondrial complex I, which is essential for the normal function of mitochondria, the energy-producing organelles within cells. Mutations in the MT-ND4 gene can lead to mitochondrial complex I deficiency, a condition that can cause a wide range of symptoms, including neurological and muscular issues, among others.
To diagnose this condition, a genetic test targeting the MT-ND4 gene can be conducted. This test is designed to identify mutations in the MT-ND4 gene that may lead to mitochondrial complex I deficiency. Early diagnosis through genetic testing is crucial for the management and treatment of the symptoms associated with this condition.
In the United Arab Emirates, DNA Labs UAE offers this specific genetic test. The cost of the MT-ND4 Gene Mitochondrial Complex I Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This specialized test provides valuable insights into the genetic basis of mitochondrial complex I deficiency, enabling healthcare providers to tailor treatments and interventions to the specific needs of the patient.
